Mark Stevens

Mark Stevens is the co-founder of Travera and serves as the Interim CEO. Mark also holds the titles of VP of Clinical Development and Director of Clinical Development within the company. Mark has a background in research and project management, previously working as a Technical Project Lead at Dana-Farber Cancer Institute and a Ph.D. Candidate at MIT. With a focus on developing mass-based biomarkers for cancer therapy guidance, Mark has demonstrated expertise in interdisciplinary research and collaboration within the scientific community.